Brainstorm Cell Therapuetics Inc (OTCBB - OTCQB:BCLI)
| 0.205 Data as of May 24 |  -0.005 / -2.38%Today’s Change | 0.17 Today|||52-Week Range 0.38 | -8.07% Year-to-Date |
Latest BCLI News | Press Releases
No recent news for Brainstorm Cell Therapuetics Inc.
Today’s Trading
| Previous close | 0.21 |
| Today’s open | 0.22 |
| Day’s range | 0.21 - 0.22 |
| Volume | 107,587 |
| Average volume (3 months) | 181,204 |
| Market cap | $31.3M |
| Dividend yield | -- |
Data as of 2:34pm ET, 05/24/2013
Growth & Valuation
| Earnings growth (last year) | +33.33% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 7.73 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Islet Sciences Inc | +0.21 | +75.00% |
| ENMDEntreMed Inc | -0.01 | -0.56% |
| OPXAOpexa Therapeutics I... | +0.07 | +4.32% |
| APPYVenaxis Inc | -0.06 | -4.41% |
Data as of 4:00pm ET, 05/24/2013
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$3.4M |
| Net profit margin | -- |
Profile
Sector Electronic Technology |
Industry Computer Peripherals |
President Chaim Lebovits |
Chief Executive Officer Alon Natanson, MBA |
Corporate headquarters New York, New York |
Forecasts
